The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 4,162 | 286,226 | SH | SOLE | 286,226 | 0 | 0 | ||
AMRYT PHARMA PLC | SPONSORED ADS | 03217L106 | 3,782 | 350,213 | SH | SOLE | 350,213 | 0 | 0 | ||
APOLLO ENDOSURGERY INC | COM | 03767D108 | 6,235 | 739,604 | SH | SOLE | 739,604 | 0 | 0 | ||
ASLAN PHARMACEUTICALS LTD | ADS | 04522R101 | 1,678 | 1,498,192 | SH | SOLE | 1,498,192 | 0 | 0 | ||
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 2,287 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 8,855 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
BENITEC BIOPHARMA INC | COM | 08205P100 | 1,539 | 587,499 | SH | SOLE | 587,499 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 1,378 | 5,744 | SH | SOLE | 5,744 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 11,073 | 80,348 | SH | SOLE | 80,348 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 1,668 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CALITHERA BIOSCIENCES INC | COM | 13089P101 | 146 | 219,791 | SH | SOLE | 219,791 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 1,744 | 45,132 | SH | SOLE | 45,132 | 0 | 0 | ||
CERUS CORP | COM | 157085101 | 7,101 | 1,042,722 | SH | SOLE | 1,042,722 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 7,301 | 850,935 | SH | SOLE | 850,935 | 0 | 0 | ||
COMPUGEN LTD | ORD | M25722105 | 699 | 162,602 | SH | SOLE | 162,602 | 0 | 0 | ||
COMPUGEN LTD | ORD | M25722105 | 245 | 57,000 | SH | Call | SOLE | 57,000 | 0 | 0 | |
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 3,178 | 111,860 | SH | SOLE | 111,860 | 0 | 0 | ||
CTI BIOPHARMA CORP | COM | 12648L601 | 3,680 | 1,483,829 | SH | SOLE | 1,483,829 | 0 | 0 | ||
CURIS INC | COM NEW | 231269200 | 952 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
CYCLACEL PHARMACEUTICALS INC | COM | 23254L603 | 1,783 | 458,466 | SH | SOLE | 458,466 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 2,652 | 58,190 | SH | SOLE | 58,190 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 1,568 | 160,526 | SH | SOLE | 160,526 | 0 | 0 | ||
ELOXX PHARMACEUTICALS INC | COM | 29014R103 | 1,363 | 1,930,092 | SH | SOLE | 1,930,092 | 0 | 0 | ||
EVOGENE LTD | SHS | M4119S104 | 481 | 293,057 | SH | SOLE | 293,057 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 2,226 | 181,886 | SH | SOLE | 181,886 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 7,106 | 128,901 | SH | SOLE | 128,901 | 0 | 0 | ||
HALOZYME THERAPEUTICS INC | COM | 40637H109 | 2,855 | 71,009 | SH | SOLE | 71,009 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 1,304 | 131,823 | SH | SOLE | 131,823 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 6,649 | 61,700 | SH | SOLE | 61,700 | 0 | 0 | ||
IMMATICS N.V | SHS | N44445109 | 5,257 | 391,155 | SH | SOLE | 391,155 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 11,237 | 1,514,411 | SH | SOLE | 1,514,411 | 0 | 0 | ||
INHIBRX INC | COM | 45720L107 | 1,077 | 24,666 | SH | SOLE | 24,666 | 0 | 0 | ||
INNATE PHARMA S A | SPONSORED ADS | 45781K204 | 839 | 184,046 | SH | SOLE | 184,046 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 2,741 | 100,621 | SH | SOLE | 100,621 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 10,206 | 195,000 | SH | SOLE | 195,000 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 6,426 | 138,006 | SH | SOLE | 138,006 | 0 | 0 | ||
JOUNCE THERAPEUTICS INC | COM | 481116101 | 2,053 | 245,829 | SH | SOLE | 245,829 | 0 | 0 | ||
KRYSTAL BIOTECH INC | COM | 501147102 | 3,265 | 46,670 | SH | SOLE | 46,670 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 935 | 66,812 | SH | SOLE | 66,812 | 0 | 0 | ||
LEAP THERAPEUTICS INC | COM | 52187K101 | 3,284 | 1,013,664 | SH | SOLE | 1,013,664 | 0 | 0 | ||
LUCIRA HEALTH INC | COM | 54948U105 | 4,434 | 515,000 | SH | SOLE | 515,000 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 36 | 49,990 | SH | SOLE | 49,990 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 1,246 | 128,582 | SH | SOLE | 128,582 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 373 | 233,183 | SH | SOLE | 233,183 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 10,182 | 320,174 | SH | SOLE | 320,174 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 8,912 | 60,757 | SH | SOLE | 60,757 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 3,195 | 67,440 | SH | SOLE | 67,440 | 0 | 0 | ||
NEXTCURE INC | COM | 65343E108 | 1,158 | 193,012 | SH | SOLE | 193,012 | 0 | 0 | ||
OTONOMY INC | COM | 68906L105 | 2,496 | 1,199,814 | SH | SOLE | 1,199,814 | 0 | 0 | ||
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 1,145 | 204,462 | SH | SOLE | 204,462 | 0 | 0 | ||
POLYPID LTD | SHS | M8001Q118 | 1,238 | 215,620 | SH | SOLE | 215,620 | 0 | 0 | ||
POSEIDA THERAPEUTICS INC | COM | 73730P108 | 1,600 | 234,932 | SH | SOLE | 234,932 | 0 | 0 | ||
RENOVACOR INC | *W EXP 99/99/999 | 75989E114 | 60 | 104,828 | SH | SOLE | 104,828 | 0 | 0 | ||
RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 5,415 | 556,890 | SH | SOLE | 556,890 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 1,677 | 10,848 | SH | SOLE | 10,848 | 0 | 0 | ||
SERES THERAPEUTICS INC | COM | 81750R102 | 2,671 | 320,602 | SH | SOLE | 320,602 | 0 | 0 | ||
SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 4,175 | 192,045 | SH | SOLE | 192,045 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLD CRPI | CLASS A ORD SHS | G8253W109 | 1,226 | 123,862 | SH | SOLE | 123,862 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CP | CLASS A ORD SHS | G8253Y105 | 1,216 | 123,862 | SH | SOLE | 123,862 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CRP | CLASS A ORD SHS | G8253T106 | 1,230 | 123,862 | SH | SOLE | 123,862 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CRP | CLASS A ORD SHS | G8253U103 | 1,225 | 123,862 | SH | SOLE | 123,862 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 22,392 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
STEREOTAXIS INC | COM NEW | 85916J409 | 2,134 | 344,236 | SH | SOLE | 344,236 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 2,189 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 3,144 | 14,551 | SH | SOLE | 14,551 | 0 | 0 | ||
VERACYTE INC | COM | 92337F107 | 9,120 | 221,362 | SH | SOLE | 221,362 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 1,098 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
VIEWRAY INC | COM | 92672L107 | 2,357 | 427,847 | SH | SOLE | 427,847 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 2,448 | 123,806 | SH | SOLE | 123,806 | 0 | 0 | ||
VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 827 | 424,181 | SH | SOLE | 424,181 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 3,124 | 100,000 | SH | SOLE | 100,000 | 0 | 0 |